Experiments

Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).

• Evaluation of genome-wide chromatin library of Stat5 binding sites in human breast cancer.

  PMID 15686596 · PMC549029 · Molecular cancer · 2005 · 8 claims · 5 setups

  Full-text index only

  A chromatin library coupled with experimental validation can productively identify novel in vivo Stat5 chromatin binding sites in cancer, including abnormal regulatory sites in tumor-specific neochromatin.

  t-47d agarose chromatin cloning

• Ectopic NMDAR expression in cancer unmasks germline-encoded autoimmunity.

  PMID 41882353 · PMC13216075 · Nature · 2026 · 8 claims · 8 setups

  Full-text index only

  GluN1 and GluN2B NMDAR subunits are ectopically expressed in cancer cells of human TNBC tumours

  breast tnbc 4t1-nmdar orthotopic bulk spatial immunofluorescence

• X-linked cancer-associated polypeptide (XCP) from lncRNA1456 modulates PHF8 histone demethylase activity to regulate the epigenome, gene expression, and cellular pathways in breast cancer.

  PMID 41922576 · PMC13099652 · Oncogene · 2026 · 8 claims · 8 setups

  Full-text index only

  lncRNA1456, previously classified as noncoding, encodes a 132 amino acid protein named XCP (X-linked Cancer-associated Polypeptide)

  mcf-7 breast recombinant polya+ lc-ms race

• LINE-1 Locus Transcription Nucleates Oncogenic Chromatin Architecture.

  PMID 41489510 · PMC13040219 · Cancer discovery · 2026 · 8 claims · 8 setups

  Full-text index only

  LINE-1 RNAs are primarily chromatin-associated nascent transcripts rather than cytosolic mRNAs

  mcf7 cancer qrt-pcr single-molecule chirp-seq

• Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potential.

  PMID 36450752 · PMC9712620 · Nature communications · 2022 · 8 claims · 8 setups

  Has reproduction · 70

  AR chromatin binding is highly heterogeneous between primary prostate tumors, with <5% of all AR binding sites (ARBS) shared by half of the 88 tumors analyzed

  prostate normal pca lncap chip-seq starr-seq luciferase